Global Growth Forecast Downgrades: As a biotechnology company with international expansion plans, ADVB's ability to secure funding, conduct R&D, and expand into new markets could be impacted by a slowing global economy. Reduced economic growth might lead to tighter venture capital and slower adoption of new medical technologies.

Interest Rate Environment: The Middle East conflict driving oil prices higher could lead to inflationary pressures and higher interest rates. This could increase borrowing costs for growth-oriented biotech companies like ADVB, affecting their R&D investments and overall valuation.

Healthcare Spending & Innovation Trends: The broader trends in healthcare spending, particularly in precision medicine and oncology diagnostics (ADVB's focus), significantly influence the stock. This includes government funding for research, regulatory approvals for new devices and treatments, and overall demand for advanced diagnostic tools.